DLL1 and tuberculosis: Based on these findings, we hypothesized that Notch signaling molecules (Notch1, DLL1 and Hes1) and Th1-type response factors (T-bet and IFN-γ), along with differences in white blood cell (WBC) parameters may serve as potential biomarkers for predicting disease progression and monitoring therapeutic effect in patients with active TB.